Horizon Therapeutics Public Ltd Co
Begin a Phase 2b pivotal trial of HZN-825 in diffuse cutaneous systemic sclerosis
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 24 Feb 2021
- Due
- 30 Jun 2021
- Checked
- 26 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Company expects to begin a Phase 2b pivotal trial in the first half of 2021 with the primary endpoint of forced vital capacity after 52 weeks of treatment.”
What we found
Evidence strength A What the grades mean
The company's 2021 filings show the HZN-825 pivotal trial in diffuse cutaneous systemic sclerosis was not started by June 2021. Its expected start moved to Q3 2021, then Q4 2021, with no initiation reported in the excerpts.
-
A Horizon Therapeutics Public Ltd Co 8-K filed 2021-08-04
“Pivotal Phase 2b trial to evaluate HZN-825 in diffuse cutaneous systemic sclerosis expected to initiate in the third quarter of 2021.” ✓ confirmed on the page
-
A Horizon Therapeutics Public Ltd Co 8-K filed 2021-11-03
“Diffuse Cutaneous Systemic Sclerosis Trial: Pivotal Phase 2b trial to evaluate HZN-825 in diffuse cutaneous systemic sclerosis, expected to initiate in the fourth quarter of 2021.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Begin
- Deliverable
- HZN-825 Phase 2b pivotal trial in dcSSc
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Horizon Therapeutics Public Ltd Co? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C492426-024317 · Corrections policy